Celemics, Inc. (KOSDAQ:331920)
South Korea · Delayed Price · Currency is KRW 10,240
-40 (-0.39%)
At close: Oct 1, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 114.5 billion as of October 1, 2026. Its market cap has increased by 368.27% in one year.
Market Cap
114.50B
Enterprise Value
92.60B
Revenue
5.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,240.00
ChartMarket Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 114.50B, a decrease of -42.84%. That is a compound annual growth rate of -8.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 114.50B | 416.56% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biodyne | 194.55B |
| BIOBIJOU | 174.53B |
| M.I.TECH Co.,Ltd | 149.04B |
| Synergy Innovation | 139.03B |
| RecensMedical | 106.92B |
| Corentec | 53.70B |
| DENTIS CO.,Ltd | 41.03B |
| Finemedix | 34.05B |